The effect of tolvaptan on renal progression and systemic inflammation in ADPKD
{{output}}
Inflammation plays a crucial role in the progression of autosomal dominant polycystic kidney disease (ADPKD). While tolvaptan is primarily known for its vasopressin V2 receptor antagonism, its potential anti-inflammatory effects remain under investigation. Thi... ...
